Ph.D., health and social care research, King’s College London; MSc., public health, London School of Hygiene & Tropical Medicine; B.A.Sc., biomedical science, McGill University
Summary of Experience
Dr. Hazra specializes in epidemiology and a wide range of health economics and outcomes research (HEOR). Her recent work spans several methodological areas, including budget impact analysis, cost-effectiveness analysis, retrospective database analysis, and systematic literature reviews. She also has experience supporting clients through the ICER review process in the US and developing global value dossiers for EU countries. Dr. Hazra has worked closely with European academic centers to conduct retrospective chart review studies and has experience conducting patient-reported outcomes (PRO) research through patient interviews, and discrete choice experiment and vignette-based utility studies. Her work spans a range of disease areas, including oncology, hematology, rheumatology, and autoimmune diseases. Dr. Hazra has published her work in several peer-reviewed journals and presented at international conferences.
The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences
Journal of Clinical Pathways, 2022
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States
Journal of Medical Economics, 2021